BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8864694)

  • 1. The selective endothelin ETA receptor antagonist FR139317 inhibits neointimal thickening in the rat.
    Takiguchi Y; Sogabe K
    Eur J Pharmacol; 1996 Aug; 309(1):59-62. PubMed ID: 8864694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular responses mediated by two types of endothelin ET(B) receptor in spontaneously hypertensive and Wistar-Kyoto rats.
    Kuwahara M; Masuda T; Tsubone H; Sugano S; Karaki H
    Eur J Pharmacol; 1996 Jan; 296(1):55-63. PubMed ID: 8720477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y; Hashimoto N; Fujita K; Morimoto S
    Eur J Pharmacol; 1997 Jan; 319(1):65-9. PubMed ID: 9030899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressor responses to endothelin-1 into the superior colliculus of rats: predominant role of endothelin ET(B) receptors.
    D'Amico M; Di Filippo C; Rossi F
    Eur J Pharmacol; 1998 Apr; 347(1):71-5. PubMed ID: 9650850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.
    Hashimoto N; Kuro T; Taira S; Matsumura Y
    J Pharm Pharmacol; 1998 Sep; 50(9):1051-8. PubMed ID: 9811167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of the two endothelin ETA receptor antagonists, BQ-123 and FR139317, on endothelin-1-induced contraction in guinea-pig iliac artery.
    Schoeffter P; Randriantsoa A; Jost B; Bruttel K
    Eur J Pharmacol; 1993 Sep; 241(2-3):165-9. PubMed ID: 8243552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model.
    Umemura K; Ishiye M; Kosuge K; Nakashima M
    Eur J Pharmacol; 1995 Feb; 275(1):17-21. PubMed ID: 7774658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
    Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
    Eur J Pharmacol; 1995 Jul; 280(3):311-6. PubMed ID: 8566099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland.
    Nagayama T; Kuwakubo F; Matsumoto T; Fukushima Y; Yoshida M; Suzuki-Kusaba M; Hisa H; Matsumura Y; Kimura T; Satoh S
    Eur J Pharmacol; 2000 Oct; 406(1):69-74. PubMed ID: 11011035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist.
    Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
    J Pharmacol Exp Ther; 1994 Oct; 271(1):156-63. PubMed ID: 7965709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats.
    Matsumura Y; Kita S; Okui T
    Eur J Pharmacol; 2001 Mar; 415(1):45-9. PubMed ID: 11245851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep.
    Miyahara T; Koizumi T; Kubo K; Hanaoka M; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Shibamoto T
    Eur J Pharmacol; 1999 Dec; 385(2-3):163-9. PubMed ID: 10607872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chelerythrine and genistein inhibit the endothelin-1-induced increase in myofilament Ca(2+) sensitivity in rabbit ventricular myocytes.
    Wang H; Endoh M
    Eur J Pharmacol; 2001 Jul; 424(2):91-6. PubMed ID: 11476754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat.
    Sun XY; Hedner T; Feng Q; Edvinsson L
    Blood Press; 1992 Aug; 1(2):108-12. PubMed ID: 1366258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats.
    Gross PM; Weaver DF; Ho LT; Pang JJ; Edvinsson L
    Neuropharmacology; 1994 Oct; 33(10):1155-66. PubMed ID: 7862251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition by TAK-044 of the inotropic effects of endothelin-1 and endothelin-3.
    Yomogida S; Maruya J; Norota I; Ishii K; Endoh M
    Eur J Pharmacol; 2004 May; 492(2-3):217-24. PubMed ID: 15178368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs.
    Nirei H; Hamada K; Shoubo M; Sogabe K; Notsu Y; Ono T
    Life Sci; 1993; 52(23):1869-74. PubMed ID: 8318117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.